ChromaDex Changes Auditors to Ernst & Young
Ticker: NAGE · Form: 8-K · Filed: Dec 16, 2024 · CIK: 1386570
| Field | Detail |
|---|---|
| Company | Chromadex Corp. (NAGE) |
| Form Type | 8-K |
| Filed Date | Dec 16, 2024 |
| Risk Level | medium |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
Topics: auditor-change, accounting
Related Tickers: CDXC
TL;DR
CDXC swapped PwC for EY as their auditor, effective Dec 13th.
AI Summary
ChromaDex Corporation announced on December 13, 2024, a change in its certifying accountant. The company has dismissed PricewaterhouseCoopers LLP as its independent registered public accounting firm and has engaged Ernst & Young LLP as its new principal accountant. This change was approved by the Audit Committee of the Board of Directors.
Why It Matters
A change in auditors can sometimes signal underlying issues or a desire for a fresh perspective on financial reporting, which investors will monitor.
Risk Assessment
Risk Level: medium — Changes in auditors can sometimes precede or coincide with financial scrutiny or restatements, warranting investor attention.
Key Players & Entities
- ChromaDex Corporation (company) — Registrant
- PricewaterhouseCoopers LLP (company) — Former Certifying Accountant
- Ernst & Young LLP (company) — New Certifying Accountant
- December 13, 2024 (date) — Date of earliest event reported
FAQ
When was the change in certifying accountant effective?
The change in certifying accountant was effective as of December 13, 2024.
Who was ChromaDex Corporation's former independent registered public accounting firm?
ChromaDex Corporation's former independent registered public accounting firm was PricewaterhouseCoopers LLP.
Who is ChromaDex Corporation's new principal accountant?
ChromaDex Corporation's new principal accountant is Ernst & Young LLP.
Who approved the change in auditors?
The change in auditors was approved by the Audit Committee of the Board of Directors.
Did the former accountant report any disagreements with the registrant?
The filing does not indicate any disagreements with PricewaterhouseCoopers LLP.
Filing Stats: 541 words · 2 min read · ~2 pages · Grade level 16.3 · Accepted 2024-12-16 16:00:17
Key Financial Figures
- $0.001 — ich registered Common Stock, par value $0.001 per share CDXC The Nasdaq Capital Mar
Filing Documents
- cdxc-20241213.htm (8-K) — 20KB
- 0001628280-24-051374.txt ( ) — 139KB
- cdxc-20241213.xsd (EX-101.SCH) — 2KB
- cdxc-20241213_lab.xml (EX-101.LAB) — 21KB
- cdxc-20241213_pre.xml (EX-101.PRE) — 12KB
- cdxc-20241213_htm.xml (XML) — 3KB
01 Changes in Registrant's Certifying Accountant
Item 4.01 Changes in Registrant's Certifying Accountant. Following a competitive request-for-proposal process during which the Audit Committee of our Board of Directors (the "Audit Committee") solicited and reviewed proposals from several accounting firms, the Audit Committee approved the engagement of Crowe LLP ("Crowe") as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2024, effective December 13, 2024. During the Company's two most recent fiscal years ended December 31, 2023 and 2022 and subsequent interim period from January 1, 2024 to December 13, 2024, neither the Company nor anyone on its behalf consulted Crowe regarding (i) the application of accounting principles to a specified transaction, either completed or proposed, or the type of audit opinion that might be rendered on the Company's consolidated financial statements, and neither a written report nor oral advice was provided to the Company that Crowe concluded was an important factor considered by the Company in reaching a decision as to any accounting, auditing or financial reporting issue, or (ii) any matter that was either the subject of a "disagreement," as that term is defined in Item 304(a)(1)(iv) of Regulation S-K, or a "reportable event," as that term is defined in Item 304(a)(1)(v) of Regulation S-K.
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. CHROMADEX CORPORATION Dated: December 16, 2024 By: /s/ Robert Fried Name: Robert Fried Chief Executive Officer